| Glenn Stebbins, PhD: | |
| Stock Ownership in medically-related fields: none | Intellectual Property Rights: none |
| Consultancies: IMPAX Laboratories, Inc.; Ceregene, Inc.; Biovail Technologies, LTD; Santhera Pharmaceuticals; i3 | Expert Testimony: none |
| Advisory Boards: none | Employment: Rush University Medical Center |
| Partnerships: none | Contracts: none |
| Honoraria: none | Royalties: none |
| Grants: NIH, Michael J. Fox Foundation for Parkinson's Research, American Cancer Society, Fragile X Foundation | Other: Editorial Board, Journal of Clinical and Experimental Neuropsychology |